These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14689867)

  • 1. [Calculation of drug information necessity factor of generic drugs].
    Iijima H; Kurosaki T; Kamei M; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2003 Dec; 123(12):1039-47. PubMed ID: 14689867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of information for generic drugs based on importance and necessity].
    Iijima H; Kamei M; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2005 Sep; 125(9):739-47. PubMed ID: 16141694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective evaluation of generic drug information.
    Iijima H; Kamei M; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2004 Jun; 124(6):341-7. PubMed ID: 15170069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Objective evaluation of generic-specific drug information].
    Iijima H; Koshimizu T; Shiragami M
    Yakugaku Zasshi; 2007 Mar; 127(3):541-5. PubMed ID: 17329940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information provided by generic and brand-name pharmaceutical manufacturers in response to a request.
    Fernandez-Llimos F; Vazquez Gomez I
    Pharm World Sci; 2007 Dec; 29(6):683-7. PubMed ID: 17464571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Availability of drug information on bioequivalence of generic products--findings of graduate interns at a university pharmacy].
    Onda M; Kanematsu M; Kitamura T; Sakai T; Sakagami K; Tanaka K; Hamahata Y; Hirooka T; Fujii K; Matsuda M; Miki H; Mashimo H; Hada R; Arakawa Y
    Yakugaku Zasshi; 2007 Jul; 127(7):1159-66. PubMed ID: 17603276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic antibiotics in Japan.
    Fujimura S; Watanabe A
    J Infect Chemother; 2012 Aug; 18(4):421-7. PubMed ID: 22684334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing patterns of dispensing branded and generic drugs for the treatment of gastroesophageal reflux disease between 2006 and 2011 in Japan: a retrospective cohort study.
    Murata K; Hinotsu S; Hamada S; Ezoe Y; Muto M; Kawakami K
    BMC Health Serv Res; 2015 Feb; 15():76. PubMed ID: 25885571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do generics offer significant savings to the UK National Health Service?
    Kanavos P
    Curr Med Res Opin; 2007 Jan; 23(1):105-16. PubMed ID: 17257472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased topical generic prices by manufacturers.
    Bhatt MD; Bhatt BD; Dorrian JT; McLellan BN
    J Am Acad Dermatol; 2019 May; 80(5):1353-1357. PubMed ID: 29544742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Firm- and drug-specific patterns of generic drug payments by US medicaid programs: 1991-2008.
    Kelton CM; Chang LV; Guo JJ; Yu Y; Berry EA; Bian B; Heaton PC
    Appl Health Econ Health Policy; 2014 Apr; 12(2):165-77. PubMed ID: 24550087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do pharmaceuticals really cost in the long run?
    Lakdawalla D; MacEwan JP; Dubois R; Westrich K; Berdud M; Towse A
    Am J Manag Care; 2017 Aug; 23(8):488-493. PubMed ID: 29087143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conformity of package inserts information to regulatory requirements among selected branded and generic medicinal products circulating on the East African market.
    Sillo HB; Masota NE; Kisoma S; Rago L; Mgoyela V; Kaale EA
    PLoS One; 2018; 13(5):e0197490. PubMed ID: 29787579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns in spontaneous adverse event reporting among branded and generic antiepileptic drugs.
    Bohn J; Kortepeter C; Muñoz M; Simms K; Montenegro S; Dal Pan G
    Clin Pharmacol Ther; 2015 May; 97(5):508-17. PubMed ID: 25670505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Competition between branded and generic drugs in Austria: evidence from the market for ACE inhibitors].
    Mahlich JC; Stadler I
    Gesundheitswesen; 2012 Jan; 74(1):23-8. PubMed ID: 21154203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower Proportion of Spontaneous Adverse Event Reports for Generic Drugs by Comparison With Original Branded Drugs at the Postmarket Stage in Japan.
    Takami A; Hirata K; Ishiguro C; Hanaoka H; Uyama Y
    Clin Pharmacol Ther; 2019 Jun; 105(6):1471-1476. PubMed ID: 30588617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011.
    Cheng N; Banerjee T; Qian J; Hansen RA
    J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of electronic prescribing on formulary compliance and generic drug utilization in the ambulatory care setting: a retrospective analysis of administrative claims data.
    Ross SM; Papshev D; Murphy EL; Sternberg DJ; Taylor J; Barg R
    J Manag Care Pharm; 2005 Jun; 11(5):410-5. PubMed ID: 15934800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.